FDA’s Hamburg Details Some Sequestration Impacts On FDA
This article was originally published in The Gray Sheet
Commissioner says allowing the sequester could slow implementation of some user fee provisions and reduce overseas inspections.
You may also be interested in...
FDA does not plan to furlough employees as a result of the across-the-board cuts to federal agencies that took effect March 1, but the shortfall will limit some “activities that have already been specifically designated and paid for with user fees.” The administration also took a step to convince Congress to give FDA full access to its user fees.
FDA and advocates wait for OMB to clarify how the estimated 7.8% budget cut should be implemented, if it is enacted. Former agency officials say it could lead to hiring freezes and program delays.
The legislation, awaiting the signature of the president, will bring greater scrutiny of device center activities by Congress and industry.